Monte Rosa Therapeutics Inc

NASDAQ:GLUE 4:00:00 PM EDT

5.54

+0.04 (+0.73%)

4:20:00 PM EDT: $5.54 0.00 (0.00%)

Market Cap (Intraday)	277.86M
Current PE	N/A
Forward PE	N/A
2yr Forward PE	N/A

See more stats

Estimates Current Quarter

Revenue	$1.4 Million
Adjusted EPS	-$0.59

See more estimates

10-Day MA	$6.13
50-Day MA	$6.39
200-Day MA	$5.51

See more pivots

Monte Rosa Therapeutics Inc Stock, NASDAQ:GLUE

321 Harrison Avenue, Suite 900, Boston, Massachusetts 02118

United States of America

Phone: +1.617.949.2643

Number of Employees: 133

http://www.monterosatx.com

Description

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.